CellWell record HH-534493
Beyond HbA1c: Alternative Glycemic Biomarkers in Hemoglobinopathies, Malignancy, and Special Clinical Populations - A Review
Manjusha Hivre; Shrirang Holkar; Deepali Vaishnav; Prashant Surkar
International Journal of Drug Delivery Technology ยท 2026
In plain language
This review of 156 studies found HbA1c is spuriously raised by 0.5-1.0% in iron deficiency and underestimated in hemoglobinopathies, with alternative markers such as glycated albumin remaining accurate where HbA1c fails.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-534493
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.